Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Nucleoside and nucleotide analogs in the treatment of chronic hepatitis B].

Enfermedades infecciosas y microbiologia clinica - 1 May 2008

Buti María

Abstract excerpt

At least 4 nucleos(t)ide analogs have been approved for the treatment of chronic hepatitis B: lamivudine, adefovir dipivoxil, entecavir, and telbivudine. The introduction of these drugs has radically changed the treatment of this disease. The advantages of these drugs are their oral administration, excellent tolerability and efficacy in all types of chronic hepatitis B (compensated and decompensated disease). The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Deoxycytidine
Share to Emtricitabine
Share to Multicenter Studies as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Nucleosides

Share to Organophosphonates

Share to Pyrimidinones

Share to Tenofovir

Share to Thymidine

Source

Identifiers

PMID: 19100229
DOI: 10.1016/s0213-005x(08)76517-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Nucleoside and nucleotide analogs in the treatment of chronic hepatitis B].PMID 19100229Read ↗

Current developments in nucleoside/nucleotide analogues for hepatitis B.Semantic proximity Read ↗

[Clinical management of patients with chronic hepatitis B virus infection].Semantic proximity Read ↗

[Future perspectives and strategies in managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].Semantic proximity Read ↗

[Management of antiviral-resistant chronic hepatitis B virus infection].Semantic proximity Read ↗

Monotherapy versus combination therapy for the treatment of chronic hepatitis B.Semantic proximity Read ↗

[Management of chronic hepatitis B].Semantic proximity Read ↗

Molecular mechanisms of resistance to antiviral therapy in patients with chronic hepatitis B.Semantic proximity Read ↗

Comparative evaluation of long-term monotherapies & combination therapies in patients with chronic hepatitis B: A pilot study.Semantic proximity Read ↗

Hepatitis B virus drug resistance to current nucleos(t)ide analogs: Mechanisms and mutation sitesSemantic proximity Read ↗

[Interferon in hepatitis B].Semantic proximity Read ↗

Review article: Nucleoside analogues for the treatment of chronic hepatitis B.Semantic proximity Read ↗

[Mutation patterns in the RT region of hepatitis B virus P gene in patients treated with nucleoside/nucleotide analogs].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.